Product Information

FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.4225 per EA under NDC 00480782056. Its NADAC has been published 139 times since Mar 20, 2024.

FDA first approved this application on Jul 2, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FINGOLIMOD 0.5 MG CAPSULE

Fingolimod
$1.4225per EA

Strength

.5 mg/1

NDC

00480782056

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FINGOLIMOD HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208008

FDA Approved

7/2/2020

TE Code

AB

On Market Since

2/14/2024

Pharmacological Classes

Sphingosine 1-Phosphate Receptor Modulators
Sphingosine 1-phosphate Receptor Modulator

Price Statistics

The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 139 times since Mar 20, 2024, and over the history we have for it it has declined 85.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4225 per EA
All-time high$10.0429 (May 15, 2024)
All-time low$1.4225 (Oct 21, 2026)
52-week high$5.7008
52-week low$1.4225
Median price$5.5648
Average price$6.1228
Largest weekly change-27.4% (Jul 22, 2026)
Weeks tracked139
Tracking sinceMar 20, 2024

Price History

1W

0.0%

1M

-9.9%

3M

-40.5%

6M

-66.1%

1Y

-75.2%

3Y

N/A

5Y

N/A

All

-85.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.4225 per EA (NDC 00480782056), effective Nov 11, 2026.

How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 85.4%. It has been tracked across 139 weekly CMS publications since Mar 20, 2024.

What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?

Since Mar 20, 2024, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $1.4225 (Oct 21, 2026) to a high of $10.0429 (May 15, 2024), with a median of $5.5648 per EA.

Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FINGOLIMOD 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures FINGOLIMOD 0.5 MG CAPSULE?

FINGOLIMOD 0.5 MG CAPSULE (NDC 00480782056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.